Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 117.5M
SVFC On Other Exchanges
Symbol
Exchange
SVFC is not on other exchanges.
As of 3:49 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

intellicell biosciences inc (SVFC) Snapshot

Open
$0.0001
Previous Close
$0.0001
Day High
$0.0002
Day Low
$0.0001
52 Week High
03/11/14 - $0.01
52 Week Low
12/17/14 - $0.0001
Market Cap
789.4K
Average Volume 10 Days
12.8M
EPS TTM
$-0.02
Shares Outstanding
7.9B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INTELLICELL BIOSCIENCES INC (SVFC)

Related News

No related news articles were found.

intellicell biosciences inc (SVFC) Related Businessweek News

No Related Businessweek News Found

intellicell biosciences inc (SVFC) Details

IntelliCell BioSciences, Inc. operates as a regenerative medicine company in the United States. It develops and commercializes regenerative medicine using adult autologous stromal vascular fraction cells derived from the blood vessels in adipose tissue. The company’s products are intended to treat various clinical conditions, such as aesthetic conditions, orthopedic and sports injuries, and pain, as well as cardiac, gastrointestinal, periodontal, and autistic disorders. It also focuses on undertaking clinical studies in partnership with universities and hospitals for osteoarthritis, gum regeneration, non-healing diabetic ulcers, multiple sclerosis, cartilage regeneration, tendon repair, facial lines and wrinkles, chronic migraine headache, bone regeneration, and hair regeneration indications. In addition, the company is involved in sourcing, selling, and distributing laboratory equipment and supplies, which are used in tissue processing activities. It also licenses its products in Canada, Australia, New Zealand, and Thailand. The company is based in New York, New York.

intellicell biosciences inc (SVFC) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $275.0K
Compensation as of Fiscal Year 2013.

intellicell biosciences inc (SVFC) Key Developments

IntelliCell BioSciences, Inc. announced delayed 10-Q filing

On 11/14/2014, IntelliCell BioSciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Intellicell Biosciences Announces Resignation of Myron Holubiak as Director

Effective October 27, 2014, the Board of Directors of Intellicell Biosciences, Inc. accepted the amicable resignation of Mr. Myron Holubiak as a director of the Company. Mr. Holubiak served on the audit committee and on the corporate governance/nominating committee at the time of his resignation. The Company intends to replace Mr. Holubiak as a board member, as well as an audit committee and corporate governance/nominating committee member, in the near future.

IntelliCell BioSciences, Inc. Announces Filing of Amendment to the its Articles of Incorporation

On September 3, 2014, Intellicell Biosciences, Inc. filed an amendment to the its articles of incorporation with the Secretary of State of the State of Nevada to increase the Company's authorized common stock from three billion five hundred million (3,500,000,000) shares of common stock to ten billion (10,000,000,000) shares of common stock.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVFC:US $0.00 USD 0.00

SVFC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Athersys Inc $1.29 USD +0.06
Biorestorative Therapies Inc $0.44 USD -0.0301
Cytori Therapeutics Inc $0.51 USD +0.0221
StemCells Inc $0.99 USD +0.106
Vericel Corp $2.88 USD +0.005
View Industry Companies
 

Industry Analysis

SVFC

Industry Average

Valuation SVFC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTELLICELL BIOSCIENCES INC, please visit www.intellicellbiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.